Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of this study is to evaluate the efficacy, dose response, safety, tolerability and PK of three doses of losmapimod (2.5mg, 7.5mg and 15mg) administered twice daily compared with placebo in subjects with COPD. The study will evaluate primarily the effects of each dose on exercise tolerance, as assessed by the six-minute walk distance (6MWD).
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease (COPD)